How is the ongoing ownership battle over Warner Bros. tied to Nashville? The Ellison family's involvement is key.

With a new year swiftly coming, Steve Miranda, Executive Vice President, Applications Development at Oracle, recently joined the CRM Playaz to discuss what the year ahead has in store in the ...

Wells Fargo expects Oracle stock to rally nearly 50% in 2026. Analyst Michael Turrin explains why in a research note to clients.

After being laid off by Oracle, Clair Todd has spent about two years job hunting, reselling antiques, and rethinking her pivot to the tech industry.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

It hasn't been that long since Oracle was an AI darling. A lot can change in a few months.

Oracle said talks for an equity deal to support its Michigan data center project remain on schedule and do not include Blue ...

Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...